Rituximab for refractory hematological manifestations of systemic lupus erythematosus and antiphospholipid syndrome

被引：0
|
作者：
Hernandez, M. C. [1 ]
Guin, L. [1 ]
Saavedra, M. A. [1 ]
Jara, L. J. [1 ]
机构：
[1] UMAE, Hosp Especialidades, Natl Med Ctr, IMSS, Mexico City, DF, Mexico
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：465 / 465
页数：1
相关论文
共 50 条
  • [31] The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus
    Venturelli, Veronica
    Abrantes, Ana Mafalda
    Rahman, Anisur
    Isenberg, David A.
    RHEUMATOLOGY, 2024, 63 (SI) : SI72 - SI85
  • [32] Antiphospholipid antibodies and the antiphospholipid syndrome in patients with systemic lupus erythematosus
    Taouli, K. M.
    Sari, R.
    Kendouci, E. H.
    Stambouli, O. B.
    Schved, J. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 419 - 419
  • [33] Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus
    Farzaneh-Far, Afshin
    Roman, Mary J.
    Lockshin, Michael D.
    Devereux, Richard B.
    Paget, Stephen A.
    Crow, Mary K.
    Davis, Adrienne
    Sammaritano, Lisa
    Levine, Daniel M.
    Salmon, Jane E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 3918 - 3925
  • [34] Catastrophic Antiphospholipid Syndrome Associated with Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report
    Shin, JinShik
    Kim, Kwang Nam
    JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (01): : 74 - 78
  • [35] The efficacy of Rituximab for refractory manifestations of the antiphospholipid syndrome - an Israeli experience
    Agmon-Levin, Nancy
    Berman, Mark
    Harel, Liora
    Yahia, Soad Haj
    Paran, Dafna
    LUPUS, 2019, 28 : 58 - 58
  • [36] Rituximab for refractory manifestations of the antiphospholipid syndrome: a multicentre Israeli experience
    Agmon-Levin, N.
    Berman, M.
    Harel, L.
    Lidar, M.
    Drori, T.
    Hajyahia, S.
    Paran, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1049 - 1055
  • [37] Rituximab for Refractory Manifestations of the Antiphospholipid Syndrome: A Multicenter Israeli Experience
    Agmon-Levin, Nancy
    Berman, Mark
    Harel, Liora
    Lidar, Merav
    Hajyahia, Soad
    Paran, Daphna
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [38] Rituximab therapy in neuropsychiatric manifestations of juvenile systemic lupus erythematosus
    Madureira, I.
    Alcafache, M.
    Silva, M. A.
    Silva, R.
    Ramos, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S74 - S74
  • [39] Therapeutic principles in systemic lupus erythematosus with antiphospholipid syndrome
    Reshetnyak, TM
    Alekberova, ZS
    Nasonov, EL
    Nasonova, VA
    TERAPEVTICHESKII ARKHIV, 1998, 70 (05) : 83 - 87
  • [40] Heart involvement in systemic lupus erythematosus and antiphospholipid syndrome
    Costedoat-Chalumeau, N.
    Le Guern, V
    Morel, N.
    REVUE DE MEDECINE INTERNE, 2021, 42 (10): : A220 - A222
12345